收藏切换
Clinical Efficacy and Pharmacokinetics/Pharmacodynamics Analysis of Intravenous Polymyxin B for Critically Ill Patients with Sepsis
收藏切换
Hao LI1a, 2, Lingyun ZUO1b, Jiahui LIN1a, 3, Mengying PI2, 4, Xiaobin LIN1a, Xiao CHEN1a, Guoping ZHONG2, Kejing TANG1a, 1c, Changjie CAI1b, Pan CHEN1a, Yanzhe XIA1a
Pharmacy Today | 2026, 36(5) : 369 - 375
Less
收藏切换
Pharmacy Today | 2026, 36(5): 369-375
Clinical Efficacy and Pharmacokinetics/Pharmacodynamics Analysis of Intravenous Polymyxin B for Critically Ill Patients with Sepsis
Full
Hao LI1a, 2, Lingyun ZUO1b, Jiahui LIN1a, 3, Mengying PI2, 4, Xiaobin LIN1a, Xiao CHEN1a, Guoping ZHONG2, Kejing TANG1a, 1c, Changjie CAI1b, Pan CHEN1a, Yanzhe XIA1a
Affiliations
  • 1a.Department of Pharmacy, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China
  • 1b.Department of Critical Care Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China
  • 1c.Division of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China
  • 2.School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, Guangdong 510006, China
  • 3.Department of Pharmacy, Hui Ya Hospital of The First Affiliated Hospital, Sun Yat-Sen University, Huizhou, Guangdong 516081, China
  • 4.Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410000, China
Published: 2026-05-25 doi: 10.12048/j.issn.1674-229X.2026.05.008
Outline
收藏切换
OBJECTIVE

To investigate the relationship between intravenous polymyxin B (PMB) exposure and clinical outcome in septic patients, and to explore the pharmacokinetic target.

METHODS

This single-center observational study enrolled septic patients who received PMB therapy between July 2021 and July 2025. Primary outcome was the clinical success rate. Secondary outcomes included 28-day all-cause mortality, 90-day survival time, bacterial clearance, 28-day ventilator/ICU/hospital-free days and incidence of PMB-related acute kidney injury (AKI). The AUCss, 0-12 h and Css, avg were analyzed for associations with outcomes, and cut-off value was determined by receiver-operating characteristic (ROC) curves. Subgroup analysis was conducted among patients receiving continuous renal replacement therapy (CRRT).

RESULTS

Of 82 septic patients, clinical success rate was 37.8%. The AUCss, 0-12 h cut-off value was 27.10 mg·h-1·L-1 (Css, avg 2.26 mg·L-1). AUCss, 0-12 h > 27.10 mg·h-1·L-1 was associated with longer 90-day survival time (ETR=1.92, P=0.039). In the CRRT subgroup, increased loading dose was associated with longer 90-day survival time (ETR=1.38, P=0.015). The incidence of PMB-related AKI was 40.54% (15/37).. Patients with AKI had higher AUCss, 0-12 h (43.51 vs. 27.23 mg·h-1·L-1, P=0.006).

CONCLUSION

PMB exposure is associated with clinical efficacy in septic patients. Maintaining an AUCss, 0-12 h > 27.10 mg·h-1·L-1 (Css, avg of 2.26 mg·L-1) enhances clinical success. Higher AUCss, 0-12 h is an independent risk factor for PMB-related AKI. Therapeutic drug monitoring is recommended to ensure efficacy and safety.

sepsis  /  polymyxin B  /  pharmacokinetic/pharmacodynamic analysis
李昊, 左凌云, 林佳慧, 皮孟颖, 林晓彬, 陈孝, 钟国平, 唐可京, 蔡常洁, 陈攀, 夏延哲. 脓毒症危重患者静脉滴注多黏菌素B的临床疗效和药动学/药效学分析. 今日药学, 2026 , 36 (5) : 369 -375 . DOI: 10.12048/j.issn.1674-229X.2026.05.008
Hao LI, Lingyun ZUO, Jiahui LIN, Mengying PI, Xiaobin LIN, Xiao CHEN, Guoping ZHONG, Kejing TANG, Changjie CAI, Pan CHEN, Yanzhe XIA. Clinical Efficacy and Pharmacokinetics/Pharmacodynamics Analysis of Intravenous Polymyxin B for Critically Ill Patients with Sepsis[J]. Pharmacy Today, 2026 , 36 (5) : 369 -375 . DOI: 10.12048/j.issn.1674-229X.2026.05.008
Year 2026 volume 36 Issue 5
181
36
Cite this Article
BibTeX
Article Info
doi: 10.12048/j.issn.1674-229X.2026.05.008
  • Receive Date:2026-02-15
  • Online Date:2026-09-23
  • Published:2026-05-25
Article Data
Affiliations
History
  • Received:2026-02-15
Funding
Affiliations
    1a.Department of Pharmacy, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China
    1b.Department of Critical Care Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China
    1c.Division of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China
    2.School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, Guangdong 510006, China
    3.Department of Pharmacy, Hui Ya Hospital of The First Affiliated Hospital, Sun Yat-Sen University, Huizhou, Guangdong 516081, China
    4.Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410000, China
References
Share
https://castjournals.cast.org.cn/joweb/jryx/EN/10.12048/j.issn.1674-229X.2026.05.008
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT